Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU class 5 homeobox 1 pseudogene 3 (POU5F1P3) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a functional gene (here, POU5F1/OCT4, a key pluripotency transcription factor), but is generally thought to lack the ability to encode a functional protein[1][3]. POU5F1P3 shares high sequence similarity with POU5F1 and is transcriptionally active in some cancers, where its expression—like its parental gene—may be altered and associated with tumor biology. Its function is not well-established; it is predicted to regulate DNA-templated transcription, potentially by acting on RNA or modulating the expression or stability of the parental gene transcript. POU5F1P3 and related pseudogenes are increasingly being studied for their roles as biomarkers or modulators in oncology due to their expression in cancer, but this molecular entity itself is not a validated therapeutic target and does not code for a functional receptor, enzyme, or protein[1][3].\n\nKey notes:\n- POU5F1P3 is a pseudogene and does not encode a functional protein, distinguishing it from its parent gene POU5F1/OCT4, which is a transcription factor critical for stem cell pluripotency and cancer biology[2][3].\n- While POU5F1P3 may have regulatory roles (potentially through RNA-mediated mechanisms) and is differentially expressed in cancers, it is neither a receptor nor a direct therapeutic target at present[1][3].\n- No known drugs directly target POU5F1P3 or its product, if any (other than possibly serving as a biomarker in research settings)[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU class 5 homeobox 1 pseudogene 3 (POU5F1P3).